Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease

Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci, Marc Humbert

Source: Eur Respir J, 54 (6) 1900585; 10.1183/13993003.00585-2019
Journal Issue: December
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci, Marc Humbert. Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease. Eur Respir J, 54 (6) 1900585; 10.1183/13993003.00585-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in sickle cell disease and laboratory markers
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease
Source: Eur Respir J, 52 (4) 1800272; 10.1183/13993003.00272-2018
Year: 2018



Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Screening for pulmonary hypertension in sickle cell disease: A regional survey
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


Prevalence of pulmonary arterial hypertension using doppler echocardiografic method in sickle cell disease
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007


Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2012; 39: 3-4
Year: 2012


Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2011; 39: 3-4
Year: 2012


Radiographic findings in sickle cell patients with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010

Pulmonary function abnormalities in Egyptian sickle cell disease patients
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011


Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012


Clinical features of pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Clinical features of pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Clinical features of pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018



Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007

Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2011; 39: 112-118
Year: 2012